{"id":"W2761245920","doi":"10.1200/jco.2014.32.15_suppl.3028","title":"Phase 2 open-label study of MEDI-551 and bendamustine versus rituximab and bendamustine in adults with relapsed or refractory CLL.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Jewish General Hospital","funders":"","keywords":"Bendamustine; Medicine; Tolerability; Internal medicine; Neutropenia; Rituximab; Adverse effect; Nausea; Chronic lymphocytic leukemia; Population; Gastroenterology; Surgery; Leukemia; Toxicity; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006543904,0.0002231091,0.00242577,0.0002773957,0.0000469076,0.00001556924,0.0003435143,0.0003893068,0.0001096508],"category_scores_gemma":[0.01635328,0.0001362896,0.00005843156,0.00031463,0.0005935621,0.0002134352,0.000336174,0.001557542,0.000002886024],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001192546,"about_ca_system_score_gemma":0.00857303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000391348,"about_ca_topic_score_gemma":0.001897797,"domain_scores_codex":[0.9949642,0.0008122648,0.002705312,0.0004119668,0.0007336603,0.0003725986],"domain_scores_gemma":[0.9885049,0.008188866,0.001635923,0.0003766194,0.0006307777,0.0006629451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5754999,0.07684459,0.008200884,0.0004573286,0.0007931767,0.005469083,0.001502753,0.000007964728,0.0001355047,0.00005401862,0.002305148,0.3287296],"study_design_scores_gemma":[0.7012341,0.2769666,0.009463022,0.0006020041,0.0004370921,0.0008616591,0.001350308,0.003374941,0.00001797285,0.00002218331,0.005538575,0.0001315598],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955591,0.0003513217,0.00001547373,0.001858711,0.0004402818,0.0007591504,0.000004548286,0.000006478276,0.001004937],"genre_scores_gemma":[0.9951741,0.0008415678,0.002887578,0.0003022264,0.000573646,0.000009539043,0.000003497907,0.00003075954,0.0001771446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3285981,"threshold_uncertainty_score":0.9970474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2117651910084442,"score_gpt":0.5352959847158193,"score_spread":0.3235307937073751,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}